Showing results (101-110 of 247) with videos related to
Sort By:
Pageof 25
International Journal of Hepatology|February 13, 2020
Avatrombopag, an Alternate Treatment Option to Reduce Platelet Transfusions in Patients with Thrombocytopenia and Chronic Liver Disease-Integrated Analyses of 2 Phase 3 StudiesFred Poordad, Norah A Terrault, Naim Alkhouri, et al.Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 11, 2017
Use of a hepatitis C virus (HCV) RNA-positive donor in a treated HCV RNA-negative liver transplant recipientIsabel Campos-Varela, Eliana Z Agudelo, Monika Sarkar, et al.Cancer|July 22, 2014
Risk prediction of hepatocellular carcinoma in patients with cirrhosis: the ADRESS-HCC risk modelJennifer A Flemming, Ju Dong Yang, Eric Vittinghoff, et al.Hepatology (Baltimore, Md.)|November 10, 2019
Medicaid Policy and Liver Transplant for Alcohol-Associated Liver DiseaseBrian P Lee, Eric Vittinghoff, Mark J Pletcher, et al.Journal of Public Health Management and Practice : JPHMP|July 27, 2019
An Evaluation of Hepatitis C Virus Telehealth Services Serving Tribal Communities: Patterns of Usage, Evolving Needs, and BarriersDavid Stephens, Jessica Leston, Norah A Terrault, et al.Digestive Diseases and Sciences|January 8, 2015
Bone Mineral Density, Bone Turnover, and Systemic Inflammation in Non-cirrhotics with Chronic Hepatitis CJennifer C Lai, Dolores M Shoback, Jacob Zipperstein, et al.Hepatology (Baltimore, Md.)|February 12, 2008
Limitations of conventionally derived chronic liver disease mortality rates: Results of a comprehensive assessmentM Michele Manos, Wendy A Leyden, Rosemary C Murphy, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 26, 2014
Restricting liver transplant recipients to younger donors does not increase the wait-list time or the dropout rate: the hepatitis C experienceJennifer A Flemming, Parsia A Vagefi, Chris E Freise, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2004
Longitudinal effect of antiretroviral therapy on markers of hepatic toxicity: impact of hepatitis C coinfectionAudrey L French, Lorie Benning, Kathryn Anastos, et al.Alimentary Pharmacology & Therapeutics|April 13, 2023
Population-attributable risk of modifiable lifestyle factors to hepatocellular carcinoma: The multi-ethnic cohortKali Zhou, Tiffany Lim, Jennifer L Dodge, et al.Pageof 25